Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Description

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Conditions

Eye Movement

Study Overview

Study Details

Study overview

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Condition
Eye Movement
Intervention / Treatment

-

Contacts and Locations

Wilmington

NeuraLight, Wilmington, Delaware, United States, 19801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men and women ages between 18 and 90 years old
  • * Normal or corrected vision
  • * Ability to follow instructions
  • * Willing and able to sign an informed consent form
  • * Inability to sit for 20 minutes on a chair in a calm manner
  • * Personal or 1st degree relative history of epilepsy
  • * Additional neurological diseases
  • * Drug or alcohol abuse

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NeuraLight,

Eitan Raveh, PhD, PRINCIPAL_INVESTIGATOR, NeuraLight

Study Record Dates

2026-12-31